rs183899632
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM2PM5BP4_Moderate
The NM_020361.5(CPA6):c.107G>T(p.Arg36Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,612,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R36C) has been classified as Uncertain significance.
Frequency
Consequence
NM_020361.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CPA6 | NM_020361.5 | c.107G>T | p.Arg36Leu | missense_variant | 1/11 | ENST00000297770.10 | |
CPA6 | XM_017013647.2 | c.107G>T | p.Arg36Leu | missense_variant | 1/7 | ||
CPA6 | XM_017013646.2 | c.-300G>T | 5_prime_UTR_variant | 1/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CPA6 | ENST00000297770.10 | c.107G>T | p.Arg36Leu | missense_variant | 1/11 | 1 | NM_020361.5 | P1 | |
CPA6 | ENST00000518549.1 | n.321G>T | non_coding_transcript_exon_variant | 1/8 | 1 | ||||
CPA6 | ENST00000479862.6 | c.107G>T | p.Arg36Leu | missense_variant, NMD_transcript_variant | 1/8 | 1 | |||
CPA6 | ENST00000638254.1 | c.107G>T | p.Arg36Leu | missense_variant, NMD_transcript_variant | 1/10 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.0000329 AC: 5AN: 152070Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000558 AC: 14AN: 250678Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135482
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1460282Hom.: 0 Cov.: 29 AF XY: 0.0000138 AC XY: 10AN XY: 726476
GnomAD4 genome ? AF: 0.0000329 AC: 5AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74410
ClinVar
Submissions by phenotype
Febrile seizures, familial, 11 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Dec 02, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CPA6 protein function. ClinVar contains an entry for this variant (Variation ID: 569405). This variant has not been reported in the literature in individuals affected with CPA6-related conditions. This variant is present in population databases (rs183899632, gnomAD 0.03%). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 36 of the CPA6 protein (p.Arg36Leu). - |
Familial temporal lobe epilepsy 5;C3280734:Febrile seizures, familial, 11 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 04, 2021 | - - |
Seizure Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Aug 14, 2019 | The c.107G>T (p.Arg36Leu) variant identified it the CPA6 gene substitutes a moderately conserved Arginine for Leucine at amino acid 36. This variant is found in gnomAD (15 heterozygotes, 0 homozygotes; allele frequency: 5.32e-5) and ExAC (5 heterozygotes, 0 homozygotes; allele frequency: 4.18e-5). In silico algorithms predict this variant to be Neutral (Provean; score: -2.36) and Damaging (SIFT; score: 0.013) to the function of the canonical transcript. This variant is classified in ClinVar as a Varaint of Uncertain Significance (VarID: 569405), and while the c.107G>T (p.Arg36Leu) variant identified in this individual has never been reported in the literature, a different change at the same nucleotide has been reported. A c.107G>A (p.Arg36His) variant in the CPA6 gene was reported in a female with Juvenile Myoclonic Epilepsy [PMID: 25875328]. The reported patient was described with myoclonic seizures, generalized tonic-clonic seizures, and absence seizures that were onset at 16.5 years of age. Functional studies on the p.Arg36His variant demonstrated 50% reduction of the mutant protein in the extracellular matrix [PMID: 25875328]. While a variant at the same nucleotide has been reported in an individual affected with epilepsy, the lack of functional data or additional evidence supporting the pathogenicity for the c.107G>T (p.Arg36Leu) variant identified in this patient results in its report here as a Variant of Uncertain Significance. - |
Familial temporal lobe epilepsy 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 30, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at